Caffeic acid phenethyl ester-mediated Nrf2 activation and IκB kinase inhibition are involved in NFκB inhibitory effect: Structural analysis for NFκB inhibition

European Journal of Pharmacology

Volumn 643, Issue 1, 2010, Pages 21-28

  Lee, Youna ^a   Shin, Dong ha ^b   Kim, Ji Hye ^a   Hong, Sungchae ^a   Choi, Daekyu ^a   Kim, Yung Jin ^a   Kwak, Mi Kyoung ^b   Jung, Yunjin ^a  

^a Pusan National University   (South Korea)

^b Yeungnam University   (South Korea)

Author keywords

Caffeic acid phenethyl ester; Inhibitory protein kappaB kinase; NF B; Nrf2; Structural analysis

Indexed keywords

CAFFEIC ACID PHENETHYL ESTER; CATECHOL; HEME OXYGENASE 1; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STRAIN HCT116; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; STRUCTURE ANALYSIS;

EID: 77955050631     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.06.016     Document Type: Article

References (38)

1. Abdel-Latif M.M., Windle H.J., Homasany B.S., Sabra K., Kelleher D. Caffeic acid phenethyl ester modulates helicobacter pylori-induced nuclear factor-kappa B and activator protein-1 expression in gastric epithelial cells. Br. J. Pharmacol. 2005, 146:1139-1147.
2. Andrews N.C., Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 1991, 19:2499.
3. Ang E.S., Pavlos N.J., Chai L.Y., Qi M., Cheng T.S., Steer J.H., Joyce D.A., Zheng M.H., Xu J. Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL-induced NF-kappaB and NFAT activity. J. Cell. Physiol. 2009, 221:642-649.
4. Balogun E., Hoque M., Gong P., Killeen E., Green C.J., Foresti R., Alam J., Motterlini R. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem. J. 2003, 371:887-895.
5. Baulig A., Garlatti M., Bonvallot V., Marchand A., Barouki R., Marano F., Baeza-Squiban A. Involvement of reactive oxygen species in the metabolic pathways triggered by diesel exhaust particles in human airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 285:L671-L679.
6. Borrelli F., Maffia P., Pinto L., Ianaro A., Russo A., Capasso F., Ialenti A. Phytochemical compounds involved in the anti-inflammatory effect of propolis extract. Fitoterapia 2002, 73(Suppl 1):S53-S63.
7. Calzado M.A., Bacher S., Schmitz M.L. NF-kappaB inhibitors for the treatment of inflammatory diseases and cancer. Curr. Med. Chem. 2007, 14:367-376.
8. Carrasco-Legleu C.E., Marquez-Rosado L., Fattel-Fazenda S., Arce-Popoca E., Perez-Carreon J.I., Villa-Trevino S. Chemoprotective effect of caffeic acid phenethyl ester on promotion in a medium-term rat hepatocarcinogenesis assay. Int. J. Cancer 2004, 108:488-492.
9. Choi D., Han J., Lee Y., Choi J., Han S., Hong S., Jeon H., Kim Y.M., Jung Y. Caffeic acid phenethyl ester is a potent inhibitor of HIF prolyl hydroxylase: structural analysis and pharmacological implication. J. Nutr. Biochem. 2009, doi:10.1016/j.jnutbio.2009.06.002.
10. Christman J.W., Blackwell T.S., Juurlink B.H. Redox regulation of nuclear factor kappa B: therapeutic potential for attenuating inflammatory responses. Brain Pathol. 2000, 10:153-162.
11. Fitzpatrick L.R., Wang J., Le T. Caffeic acid phenethyl ester, an inhibitor of nuclear factor-kappaB, attenuates bacterial peptidoglycan polysaccharide-induced colitis in rats. J. Pharmacol. Exp. Ther. 2001, 299:915-920.
12. Ho C.C., Lin S.S., Chou M.Y., Chen F.L., Hu C.C., Chen C.S., Lu G.Y., Yang C.C. Effects of CAPE-like compounds on HIV replication in vitro and modulation of cytokines in vivo. J. Antimicrob. Chemother. 2005, 56:372-379.
13. Itoh K., Mochizuki M., Ishii Y., Ishii T., Shibata T., Kawamoto Y., Kelly V., Sekizawa K., Uchida K., Yamamoto M. Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12, 14)-prostaglandin j(2). Mol. Cell. Biol. 2004, 24:36-45.
14. Jeong W.S., Kim I.W., Hu R., Kong A.N. Modulatory properties of various natural chemopreventive agents on the activation of NF-kappaB signaling pathway. Pharm. Res. 2004, 21:661-670.
15. Kapturczak M.H., Wasserfall C., Brusko T., Campbell-Thompson M., Ellis T.M., Atkinson M.A., Agarwal A. Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am. J. Pathol. 2004, 165:1045-1053.
16. Kim E.H., Surh Y.J. 15-deoxy-Delta12, 14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors. Biochem. Pharmacol. 2006, 72:1516-1528.
17. Lee T.S., Tsai H.L., Chau L.Y. Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflammatory effect of low dose 15-deoxy-Delta 12, 14-prostaglandin J2. J. Biol. Chem. 2003, 278:19325-19330.
18. Li N., Nel A.E. Role of the Nrf2-mediated signaling pathway as a negative regulator of inflammation: implications for the impact of particulate pollutants on asthma. Antioxid. Redox Signal. 2006, 8:88-98.
19. Li Q., Verma I.M. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2002, 2:725-734.
20. Li W., Khor T.O., Xu C., Shen G., Jeong W.S., Yu S., Kong A.N. Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis. Biochem. Pharmacol. 2008, 76:1485-1489.
21. May M.J., D'Acquisto F., Madge L.A., Glockner J., Pober J.S., Ghosh S. Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 2000, 289:1550-1554.
22. Natarajan K., Singh S., Burke T.R., Grunberger D., Aggarwal B.B. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc. Natl Acad. Sci. USA 1996, 93:9090-9095.
23. Onori P., DeMorrow S., Gaudio E., Franchitto A., Mancinelli R., Venter J., Kopriva S., Ueno Y., Alvaro D., Savage J., Alpini G., Francis H. Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-kappaB and induction of apoptosis. Int. J. Cancer 2009, 125:565-576.
24. Park J.H., Lee J.K., Kim H.S., Chung S.T., Eom J.H., Kim K.A., Chung S.J., Paik S.Y., Oh H.Y. Immunomodulatory effect of caffeic acid phenethyl ester in Balb/c mice. Int. Immunopharmacol. 2004, 4:429-436.
25. Rossi A., Kapahi P., Natoli G., Takahashi T., Chen Y., Karin M., Santoro M.G. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 2000, 403:103-108.
26. Satoh T., Kosaka K., Itoh K., Kobayashi A., Yamamoto M., Shimojo Y., Kitajima C., Cui J., Kamins J., Okamoto S., Izumi M., Shirasawa T., Lipton S.A. Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1. J. Neurochem. 2008, 104:1116-1131.
27. Shembade N., Harhaj N.S., Liebl D.J., Harhaj E.W. Essential role for TAX1BP1 in the termination of TNF-alpha-, IL-1- and LPS-mediated NF-kappaB and JNK signaling. EMBO J. 2007, 26:3910-3922.
28. Shim G.S., Manandhar S., Shin D.H., Kim T.H., Kwak M.K. Acquisition of doxorubicin resistance in ovarian carcinoma cells accompanies activation of the NRF2 pathway. Free Radic. Biol. Med. 2009, 47:1619-1631.
29. Son S., Lewis B.A. Free radical scavenging and antioxidative activity of caffeic acid amide and ester analogues: structure-activity relationship. J. Agric. Food Chem. 2002, 50:468-472.
30. Song J.J., Cho J.G., Hwang S.J., Cho C.G., Park S.W., Chae S.W. Inhibitory effect of caffeic acid phenethyl ester (CAPE) on LPS-induced inflammation of human middle ear epithelial cells. Acta Otolaryngol. 2008, 128:1303-1307.
31. Tanaka K., Kawakami T., Tateishi K., Yashiroda H., Chiba T. Control of IkappaBalpha proteolysis by the ubiquitin-proteasome pathway. Biochimie 2001, 83:351-356.
32. Tang E.D., Wang C.Y., Xiong Y., Guan K.L. A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha. J. Biol. Chem. 2003, 278:37297-37305.
33. Thimmulappa R.K., Lee H., Rangasamy T., Reddy S.P., Yamamoto M., Kensler T.W., Biswal S. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J. Clin. Invest. 2006, 116:984-995.
34. Tong K.I., Kobayashi A., Katsuoka F., Yamamoto M. Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism. Biol. Chem. 2006, 387:1311-1320.
35. Toyoda T., Tsukamoto T., Takasu S., Shi L., Hirano N., Ban H., Kumagai T., Tatematsu M. Anti-inflammatory effects of caffeic acid phenethyl ester (CAPE), a nuclear factor-kappaB inhibitor, on Helicobacter pylori-induced gastritis in Mongolian gerbils. Int. J. Cancer 2009, 125:1786-1795.
36. Urban M.B., Schreck R., Baeuerle P.A. NF-kappa B contacts DNA by a heterodimer of the p50 and p65 subunit. EMBO J. 1991, 10:1817-1825.
37. Xu C., Shen G., Chen C., Gelinas C., Kong A.N. Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells. Oncogene 2005, 24:4486-4495.
38. Yu Y., Wan Y., Huang C. The biological functions of NF-kappaB1 (p50) and its potential as an anti-cancer target. Curr. Cancer Drug Targets 2009, 9:566-571.